Temporo-parietal junction stimulation in the treatment of depersonalization disorder

Psychiatry Research

Volumn 186, Issue 1, 2011, Pages 138-140

  Mantovani, Antonio ^a,b   Simeon, Daphne ^c   Urban, Nina ^a   Bulow, Peter ^a   Allart, Anouk ^a   Lisanby, Sarah ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Depersonalization disorder; Repetitive Transcranial Magnetic Stimulation; Temporo parietal junction

Indexed keywords

ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; LORAZEPAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPERSONALIZATION; FEMALE; HUMAN; MALE; PARIETAL LOBE; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RETREATMENT; SYMPTOM; TEMPORAL LOBE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CROSS-OVER STUDIES; DEEP BRAIN STIMULATION; DEPERSONALIZATION; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PARIETAL LOBE; PSYCHIATRIC STATUS RATING SCALES; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 79951852327     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.08.022     Document Type: Article

References (10)

1. Blanke O., Ortigue S., Landis T., Seeck M. Inducing illusory own-body perceptions. Nature 2002, 419:269-270.
2. Blanke O., Mohr C., Michel C.M., Pascual-Leone A., Brugger P., Seeck M., Landis T., Thut G. Linking out-of-body experience and self processing to mental own-body imagery at the temporoparietal junction. The Journal of Neuroscience 2005, 25:550-557.
3. Jiménez-Genchi A.M. Repetitive transcranial magnetic stimulation improves depersonalization: a case report. CNS Spectrums 2004, 9:375-376.
4. Mayberg H.S. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clinics of North America 2003, 13:805-815.
5. Phillips M.L., Sierra M. Depersonalization disorder: a functional neuroanatomical perspective. Stress 2003, 6:157-165.
6. Schutter D.J., Laman D.M., van Honk J., Vergouwen A.C., Koerselman G.F. Partial clinical response to 2weeks of 2Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression. The International Journal of Neuropsychopharmacology 2009, 12:643-650.
7. Sierra M. Depersonalization disorder: pharmacological approaches. Expert Review of Neurotherapeutics 2008, 8:19-26.
8. Sierra M., Berrios G.E. The Cambridge Depersonalisation Scale: a new instrument for the measurement of depersonalisation. Psychiatry Research 2000, 93:163-164.
9. Simeon D., Guralnik O., Hazlett E.A., Spiegel-Cohen J., Hollander E., Buchsbaum M.S. Feeling unreal: a PET study of depersonalization disorder. The American Journal of Psychiatry 2000, 157:1782-1788.
10. Simeon D., Guralnik O., Schmeidler J., Knutelska M. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. The British Journal of Psychiatry 2004, 185:31-36.